Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

BACKGROUND: Because atopic dermatitis does not heal completely, associated severe atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) often require long-term treatment. This study aims to evaluate the long-term outcomes of using 0.1% tacrolimus eye drops to treat these severe all...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Allergy Asthma Clin Immunol
Hlavní autoři: Yazu, Hiroyuki, Fukagawa, Kazumi, Shimizu, Eisuke, Sato, Yasunori, Fujishima, Hiroshi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7852099/
https://ncbi.nlm.nih.gov/pubmed/33522964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-021-00513-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky